Published in
Springer Nature [academic journals on nature.com], Prostate Cancer and Prostatic Diseases, 4(25), p. 762-769, 2022
DOI: 10.1038/s41391-022-00524-7
Links
Tools
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
Journal article published in 2022 by
Landon C. Brown,
Susan Halabi,
Jason A. Somarelli,
Michael Humeniuk,
Yuan Wu 
,
Taofik Oyekunle,
Lauren Howard,
Jiaoti Huang,
Monika Anand,
Catrin Davies,
Prekshaben Patel,
Janet Staats,
Kent J. Weinhold,
Michael R. Harrison,
Tian Zhang
and other authors.
,
Taofik Oyekunle,
Lauren Howard,
Jiaoti Huang,
Monika Anand,
Catrin Davies,
Prekshaben Patel,
Janet Staats,
Kent J. Weinhold,
Michael R. Harrison,
Tian Zhang
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 